Published in Nucl Med Biol on October 01, 2001
Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. Biomed Eng Online (2004) 0.88
Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors. Bioconjug Chem (2009) 0.83
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter. Invest New Drugs (2010) 0.79
In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer (68)Ga-NODAGA-Procainamide (PCA). J Cancer (2017) 0.75
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr Med Chem Anticancer Agents (2003) 1.49
Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J (1995) 1.40
T2 maximum likelihood estimation from multiple spin-echo magnitude images. Magn Reson Med (1996) 1.24
Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med (1996) 1.14
Methionine dependency and cancer treatment. Cancer Treat Rev (2003) 1.11
Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates. Bioconjug Chem (2000) 1.05
In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Br J Dermatol (2004) 1.03
Upregulation of Jun and Fos family members and permanent JNK activity lead to constitutive AP-1 activation in Theileria-transformed leukocytes. Mol Biochem Parasitol (1998) 0.98
New quaternary ammonium oxicam derivatives targeted toward cartilage: synthesis, pharmacokinetic studies, and antiinflammatory potency. J Med Chem (1999) 0.97
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). J Nucl Med (1993) 0.95
Comparison between 180 degrees and 360 degrees data collection in technetium-99m MIBI SPECT of the myocardium. J Nucl Med (1989) 0.94
[Validation of an ultrasonographic method of gastric emptying measurement in men]. Gastroenterol Clin Biol (1991) 0.94
Constitutive PI3-K activity is essential for proliferation, but not survival, of Theileria parva-transformed B cells. Cell Microbiol (2000) 0.92
[Endocytosis and secretion in cultured anterior pituitary cells. Action of hypothalamic hormones]. J Microsc Biol Cell (1976) 0.92
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med (1991) 0.89
Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging. J Nucl Med (2001) 0.88
[Resistance in cerebrospinal fluid flow in normal pressure hydrocephalus]. Rev Neurol (Paris) (1975) 0.88
Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol (1998) 0.88
Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporos Int (2006) 0.87
O6-(alkyl/aralkyl)guanosine and 2'-deoxyguanosine derivatives: synthesis and ability to enhance chloroethylnitrosourea antitumor action. J Med Chem (1997) 0.86
Tissue distribution and metabolism in rat of an ethynesulphonamide with filaricidal activity. Xenobiotica (1997) 0.85
Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice. Cancer Res (2000) 0.84
New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results. J Med Chem (1985) 0.83
Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases. Cells Tissues Organs (2006) 0.83
Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy. Cell Mol Biol (Noisy-le-grand) (2001) 0.83
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent. Melanoma Res (2002) 0.83
Ultrasonic visualization of tablets in the gastrointestinal tract. J Nucl Med (1988) 0.83
Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Cancer Chemother Pharmacol (1980) 0.83
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients. Ann Oncol (2002) 0.83
Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agents. Drug Metab Dispos (2000) 0.83
Simultaneous noninvasive evaluation of gastric emptying and orocaecal transit times. Use in studying the actions of cisapride in diabetic patients. Eur J Clin Pharmacol (1992) 0.82
Biodegradability of poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophage cell line. Biomaterials (2004) 0.82
Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain. Osteoporos Int (2008) 0.82
Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma. Melanoma Res (2000) 0.82
Effect of chloroquine on thyroliberin interaction with clonal rat prolactin cells. Cytochemical correlates. Neuroendocrinology (1982) 0.82
Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats. Drug Metab Dispos (1985) 0.81
Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting. Eur J Nucl Med (1999) 0.81
A comparison between conventional scintigraphy and emission tomography with thallium-201 in the detection of myocardial infarction: concise communication. J Nucl Med (1982) 0.81
In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med (1993) 0.80
Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes. J Pharmacol Exp Ther (1994) 0.80
Metabolism of 2-chloroethyl nitrosocarbamoylcystamine by rat liver subcellular fractions. Drug Metab Dispos (1986) 0.80
Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats. J Biomed Mater Res A (2006) 0.80
In vitro binding of oxime acetylcholinesterase reactivators to proteoglycans synthesized by cultured chondrocytes and fibroblasts. Biochem Pharmacol (1992) 0.80
Disposition in rat of a new fluorinated, biocompatible, non-ionic telomeric carrier. Xenobiotica (1994) 0.79
Fusion of Leishmania amazonensis parasitophorous vacuoles with phagosomes containing zymosan particles: cinemicrographic and ultrastructural observations. Braz J Med Biol Res (1996) 0.79
Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution. Pigment Cell Melanoma Res (2010) 0.79
Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells. Br J Pharmacol (2007) 0.79
Isotopic effect study of propofol deuteration on the metabolism, activity, and toxicity of the anesthetic. J Med Chem (2002) 0.79
Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model. Cancer Res (2001) 0.79
Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice. Drug Metab Dispos (1998) 0.79
Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells. Radiat Res (2000) 0.78
[Experimental study of new indomonocarbocyanins with selective biliary elimination]. Biomedicine (1974) 0.78
3D modeling in myocardial 201TL SPECT. Comput Med Imaging Graph (1994) 0.78
DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells. Cancer Res (1990) 0.78
[Possibilities offered by new indomonocarbocyanines for functional exploration of the liver]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.78
Circadian variation in O6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects. Int J Cancer (2001) 0.78
[Normal pressure hydrocephalus. Pre- and postoperative study of 56 cases (author's transl)]. Neurochirurgie (1981) 0.78
Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme. Drugs Exp Clin Res (1992) 0.78
Transposed ciliary microtubules in Kartagener's syndrome. A case report with electron microscopy of bronchial and nasal brushings. Acta Cytol (1985) 0.78
Labeling of human lymphocytes with 99mTc by means of stannous pyrophosphate. Scintigraphic applications. Eur J Nucl Med (1982) 0.78
[Letter: Scintigraphic study of the distribution of human lymphocytes labelled with 99m technetium. Preliminary results]. Nouv Presse Med (1976) 0.78
Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice. Am J Physiol Regul Integr Comp Physiol (2001) 0.78
Comparison of histomorphometric descriptors of bone architecture with dual-energy X-ray absorptiometry for assessing bone loss in the orchidectomized rat. Osteoporos Int (2002) 0.78
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents. Nucl Med Biol (1995) 0.78